SJS Investment Consulting’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68K Sell
25
-2
-7% -$131 ﹤0.01% 1653
2026
Q1
$212 Buy
27
+17
+170% +$275 ﹤0.01% 1971
2025
Q4
$175 Buy
+10
New +$194 ﹤0.01% 1840
2023
Q3
Hold
0
-$87 1633
2023
Q2
Hold
0
1528
2023
Q1
Hold
0
-$81 1581
2022
Q4
Hold
0
1505
2022
Q3
Hold
0
1005

Other funds holding AGL

SJS Investment Consulting's AGL Position: Q2 2026 in Review

SJS Investment Consulting reduced its Agilon Health (AGL) stake by 7.4% in Q2 2026, selling an estimated $131 and leaving 25 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

SJS Investment Consulting first reported a position in AGL in Q4 2025 and has held it in 3 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • SJS Investment Consulting held 25 shares of Agilon Health worth $2.68K as of Q2 2026.
  • SJS Investment Consulting sold 2 Agilon Health shares in Q2 2026, an estimated $131.
  • Agilon Health made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1653 holding.
  • SJS Investment Consulting first reported a position in Agilon Health in Q4 2025 and has held it in 3 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.